Vaccine injection site matters: qualitative and quantitative defects in CD8 T cells primed as a function of proximity to the tumor in a murine glioma model
about
Overview of current immunotherapeutic strategies for gliomaThe impact of the myeloid response to radiation therapyImmunotherapy advances for glioblastomaEffect of vaccine administration modality on immunogenicity and efficacy.Immunotherapy of Malignant Tumors in the Brain: How Different from Other Sites?Dendritic cell-based vaccine efficacy: aiming for hot spotsSite-dependent recruitment of inflammatory cells determines the effective dose of Leishmania majorCombination of an agonistic anti-CD40 monoclonal antibody and the COX-2 inhibitor celecoxib induces anti-glioma effects by promotion of type-1 immunity in myeloid cells and T-cells.CD200 in CNS tumor-induced immunosuppression: the role for CD200 pathway blockade in targeted immunotherapy.Effective Treatment of Established GL261 Murine Gliomas through Picornavirus Vaccination-Enhanced Tumor Antigen-Specific CD8+ T Cell Responses.Dendritic Cell-Based Vaccines that Utilize Myeloid Rather than Plasmacytoid Cells Offer a Superior Survival Advantage in Malignant Glioma.Victory and defeat in the induction of a therapeutic response through vaccine therapy for human and canine brain tumors: a review of the state of the art.Improved Treatment Efficacy of Antiangiogenic Therapy when Combined with Picornavirus Vaccination in the GL261 Glioma Model.Monomeric annexin A2 is an oxygen-regulated toll-like receptor 2 ligand and adjuvant.Profound impairment of adaptive immune responses by alkylating chemotherapyTransnuclear TRP1-specific CD8 T cells with high or low affinity TCRs show equivalent antitumor activity.Dendritic cell vaccination in pediatric gliomas: lessons learnt and future perspectives.Various ways to improve whole cancer cell vaccines.Vaccine adjuvant uses of poly-IC and derivatives.The development of dendritic cell vaccine-based immunotherapies for glioblastoma.A Novel Vaccine Targeting Glypican-3 as a Treatment for Hepatocellular Carcinoma.Intratumoral oncolytic adenoviral treatment modulates the glioma microenvironment and facilitates systemic tumor-antigen-specific T cell therapy.Viral based vaccine TG4010 induces broadening of specific immune response and improves outcome in advanced NSCLCTargeting latency-associated peptide promotes antitumor immunity.Anti-PD-1 antitumor immunity is enhanced by local and abrogated by systemic chemotherapy in GBM.Therapeutic Immune Modulation against Solid Cancers with Intratumoral Poly-ICLC: A Pilot Trial
P2860
Q26776345-36BF2058-443F-4024-9805-00A993886EE1Q26851643-0A5E1EA8-F431-499A-B446-C42DFF35A7FEQ26866513-55DB267B-743B-4589-AA27-2CCE8E322953Q27692376-B1FA4A99-9072-41C2-86E7-F4138718D49CQ28078539-27DF2EAA-BFB1-4746-A001-D615DF16F675Q28082680-7DD9023B-5F24-441F-948A-7B396CBDFCDEQ33899666-415E912B-CBF9-43AA-A742-13857B49A98BQ34457611-552AB6EE-AF36-43B8-A0AD-BBD7A36630B9Q34976095-67749310-1897-4A86-B858-5517E782F16BQ35561280-47367DBE-014F-48C9-AD34-E2E692AF5AABQ35763478-F845BF35-249A-4BA8-9E82-7676B1D9DEB6Q35799695-083DBA74-91C3-4D20-AAED-7557AE321A2CQ36484434-477B58A4-1DD3-4823-9CB4-0622350BFAC6Q36584178-9863E56A-1FD5-456C-9795-145CE5637919Q36922577-226D3181-1949-4441-B8F0-CA521BC38CD4Q37494158-04968224-D3D8-4461-91E6-698B3131574EQ38176625-41180A66-09F9-4551-B355-E1BFE7F25289Q38206582-282C4096-0858-4A4C-858A-FCF20DF3BD5CQ38259510-8F2989E7-80D0-44EA-9E0F-47AE75C666F7Q38990679-E4E1E6BE-034C-4433-BFE9-503BC964A5A3Q40069479-A7930D41-6C68-410F-AEE0-90B98564C6ABQ40982444-9BE80776-5C4F-413C-A61F-76D8FFAA09F7Q41706953-4AB3934D-DCF7-4569-A0D1-C22A9A38DA79Q42626385-0F67FE8A-69CD-424A-8C3B-308C66C0BBF8Q47161862-20375DDB-B67B-46D7-86FD-09C1877F2E96Q57462243-B0D0FF57-B212-4A0C-B33C-1FE449A17738
P2860
Vaccine injection site matters: qualitative and quantitative defects in CD8 T cells primed as a function of proximity to the tumor in a murine glioma model
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Vaccine injection site matters ...... tumor in a murine glioma model
@ast
Vaccine injection site matters ...... tumor in a murine glioma model
@en
type
label
Vaccine injection site matters ...... tumor in a murine glioma model
@ast
Vaccine injection site matters ...... tumor in a murine glioma model
@en
prefLabel
Vaccine injection site matters ...... tumor in a murine glioma model
@ast
Vaccine injection site matters ...... tumor in a murine glioma model
@en
P2093
P2860
P356
P1476
Vaccine injection site matters ...... tumor in a murine glioma model
@en
P2093
Adam J Litterman
Andres M Salazar
Brian M Andersen
John R Ohlfest
Junzhe Xia
Lauryn E Swier
Michael R Olin
P2860
P304
P356
10.4049/JIMMUNOL.1201557
P407
P577
2012-12-17T00:00:00Z